RAM
TMO icon

Rempart Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Rempart Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5M Sell
46,972
-444
-0.9% -$213K 4.83% 7
2026
Q1 		$23.3M Sell
47,416
-4,537
-9% -$2.46M 4.9% 9
2025
Q4 		$30.1M Sell
51,953
-1,197
-2% -$677K 5.69% 2
2025
Q3 		$25.8M Buy
53,150
+272
+0.5% +$127K 4.77% 8
2025
Q2 		$21.4M Buy
52,878
+7,242
+16% +$3.03M 4.12% 13
2025
Q1 		$22.7M Sell
45,636
-335
-0.7% -$181K 4.69% 9
2024
Q4 		$23.9M Sell
45,971
-11
-0% -$6.05K 4.76% 7
2024
Q3 		$27.7M Sell
45,982
-440
-0.9% -$260K 5.14% 5
2024
Q2 		$25.7M Sell
46,422
-1,453
-3% -$832K 5.06% 3
2024
Q1 		$27.8M Buy
47,875
+129
+0.3% +$72.4K 5.35% 3
2023
Q4 		$25.3M Buy
47,746
+31
+0.1% +$15K 5.23% 3
2023
Q3 		$24.2M Buy
47,715
+136
+0.3% +$72.5K 5.38% 3
2023
Q2 		$24.8M Buy
47,579
+1,313
+3% +$709K 5.18% 3
2023
Q1 		$26.7M Sell
46,266
-287
-0.6% -$162K 5.9% 1
2022
Q4 		$25.6M Buy
46,553
+1,283
+3% +$680K 6.04% 1
2022
Q3 		$23M Sell
45,270
-630
-1% -$353K 5.95% 1
2022
Q2 		$24.9M Buy
45,900
+234
+0.5% +$129K 5.84% 1
2022
Q1 		$27M Sell
45,666
-3,173
-6% -$1.82M 5.49% 3
2021
Q4 		$32.6M Sell
48,839
-2,195
-4% -$1.37M 6.18% 2
2021
Q3 		$29.2M Sell
51,034
-2,711
-5% -$1.49M 6.14% 2
2021
Q2 		$27.1M Sell
53,745
-1,186
-2% -$560K 5.6% 2
2021
Q1 		$25.1M Sell
54,931
-669
-1% -$319K 6.61% 2
2020
Q4 		$25.9M Buy
+55,600
New +$26.1M 7.35% 2

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Rempart Asset Management's TMO Position: Q2 2026 in Review

Rempart Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 0.94% in Q2 2026, selling an estimated $213K and leaving 46,972 shares worth $23.5M. The position accounts for 4.83% of the portfolio, ranked #7.

Rempart Asset Management first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $32.6M in Q4 2021. 419 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Rempart Asset Management held 46,972 shares of Thermo Fisher Scientific worth $23.5M as of Q2 2026.
  • Rempart Asset Management sold 444 Thermo Fisher Scientific shares in Q2 2026, an estimated $213K.
  • Thermo Fisher Scientific made up 4.83% of Rempart Asset Management's portfolio in Q2 2026, its #7 holding.
  • Rempart Asset Management first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • Rempart Asset Management's Thermo Fisher Scientific position peaked at $32.6M in Q4 2021.
  • 419 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Rempart Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.